5 Things to Know About Aligos Therapeutics!

$ALGS Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology company, has discontinued development of ALG-020572, intended for the treatment of chronic hepatitis B (CHB).  ...read more